387 related articles for article (PubMed ID: 34888288)
1. COVID-19 Vaccine Hesitancy in the United States: A Systematic Review.
Yasmin F; Najeeb H; Moeed A; Naeem U; Asghar MS; Chughtai NU; Yousaf Z; Seboka BT; Ullah I; Lin CY; Pakpour AH
Front Public Health; 2021; 9():770985. PubMed ID: 34888288
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
[TBL] [Abstract][Full Text] [Related]
3. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
4. Determinants and Trends of COVID-19 Vaccine Hesitancy and Vaccine Uptake in a National Cohort of US Adults: A Longitudinal Study.
Rane MS; Kochhar S; Poehlein E; You W; Robertson MM; Zimba R; Westmoreland DA; Romo ML; Kulkarni SG; Chang M; Berry A; Parcesepe AM; Maroko AR; Grov C; Nash D;
Am J Epidemiol; 2022 Mar; 191(4):570-583. PubMed ID: 34999751
[TBL] [Abstract][Full Text] [Related]
5. Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study on a Mexican Population Using an Online Questionnaire (COV-AHQ).
Delgado-Gallegos JL; Padilla-Rivas GR; Zúñiga-Violante E; Avilés-Rodríguez G; Arellanos-Soto D; Gastelum-Arias LJ; Franco Villareal H; Cosío-León MLÁ; Romo-Cardenas GS; Moreno-Treviño MG; Moreno-Cuevas JE; Islas JF
Front Public Health; 2021; 9():728690. PubMed ID: 34900890
[TBL] [Abstract][Full Text] [Related]
6. Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.
Trent M; Seale H; Chughtai AA; Salmon D; MacIntyre CR
Vaccine; 2022 Apr; 40(17):2498-2505. PubMed ID: 34218963
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey.
Luk TT; Zhao S; Wu Y; Wong JY; Wang MP; Lam TH
Vaccine; 2021 Jun; 39(27):3602-3607. PubMed ID: 34034950
[TBL] [Abstract][Full Text] [Related]
8. Deliberation, Dissent, and Distrust: Understanding Distinct Drivers of Coronavirus Disease 2019 Vaccine Hesitancy in the United States.
Tram KH; Saeed S; Bradley C; Fox B; Eshun-Wilson I; Mody A; Geng E
Clin Infect Dis; 2022 Apr; 74(8):1429-1441. PubMed ID: 34272559
[TBL] [Abstract][Full Text] [Related]
9. Coronavirus Disease-2019 Vaccine Hesitancy.
Hammershaimb EA; Campbell JD; O'Leary ST
Pediatr Clin North Am; 2023 Apr; 70(2):243-257. PubMed ID: 36841593
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.
Ehde DM; Roberts MK; Humbert AT; Herring TE; Alschuler KN
Mult Scler Relat Disord; 2021 Sep; 54():103163. PubMed ID: 34325399
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Vaccine Hesitancy and How to Address It.
Rittle C
Workplace Health Saf; 2022 Feb; 70(2):56-62. PubMed ID: 35073804
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
[TBL] [Abstract][Full Text] [Related]
13. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey.
Hong J; Xu XW; Yang J; Zheng J; Dai SM; Zhou J; Zhang QM; Ruan Y; Ling CQ
J Integr Med; 2022 Jan; 20(1):34-44. PubMed ID: 34774463
[TBL] [Abstract][Full Text] [Related]
14. Cognitive underpinnings of COVID-19 vaccine hesitancy.
Acar-Burkay S; Cristian DC
Soc Sci Med; 2022 May; 301():114911. PubMed ID: 35395612
[TBL] [Abstract][Full Text] [Related]
15. What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis.
Truong J; Bakshi S; Wasim A; Ahmad M; Majid U
Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34244738
[TBL] [Abstract][Full Text] [Related]
16. A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries.
Moola S; Gudi N; Nambiar D; Dumka N; Ahmed T; Sonawane IR; Kotwal A
J Glob Health; 2021; 11():05027. PubMed ID: 34912550
[TBL] [Abstract][Full Text] [Related]
17. Parental COVID-19 Vaccine Hesitancy in the United States.
Ruiz JB; Bell RA
Public Health Rep; 2022; 137(6):1162-1169. PubMed ID: 35915993
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment.
Kreps SE; Kriner DL
Vaccine; 2021 Jun; 39(24):3250-3258. PubMed ID: 33966909
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand.
Sirikalyanpaiboon M; Ousirimaneechai K; Phannajit J; Pitisuttithum P; Jantarabenjakul W; Chaiteerakij R; Paitoonpong L
BMC Infect Dis; 2021 Nov; 21(1):1174. PubMed ID: 34809607
[TBL] [Abstract][Full Text] [Related]
20. Determinants of COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy: findings from a national population survey of U.S. adults.
Levin J; Bradshaw M
BMC Public Health; 2022 May; 22(1):1047. PubMed ID: 35614396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
